Cargando…
Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains
INTRODUCTION: The B.1.1.529 (Omicron) variant of SARS-CoV-2 is the most antigenically unique SARS-CoV-2 variant of concern to date, which is currently widespread across the world. Omicron variant and its sublineages contain a plethora of mutations than other variants of concern, which increases thei...
Autores principales: | Chowdhury, Selia, Chowdhury, Md. Shahraj, Chowdhury, Nurjahan Shipa, Chowdhury, Samia, Chowdhury, Shajeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551331/ https://www.ncbi.nlm.nih.gov/pubmed/36214233 http://dx.doi.org/10.1177/03946320221133001 |
Ejemplares similares
-
Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review
por: Chowdhury, Selia, et al.
Publicado: (2023) -
Association of Guillain–Barré syndrome following COVID-19 vaccination
por: Chowdhury, Selia, et al.
Publicado: (2023) -
COVID-19 and Pregnancy
por: Chowdhury, Selia, et al.
Publicado: (2022) -
Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
por: Chowdhury, Selia, et al.
Publicado: (2021) -
Novel Oral CGRP Receptor Antagonist Atogepant in the Prevention of Migraine
por: Chowdhury, Selia, et al.
Publicado: (2023)